Natco Pharma Ltd. NSE: NATCOPHARM | BSE: 524816

Strong Performer, Under Radar

Download real time

845.80 32.25 (3.96%)

43.80% Fall from 52W High

4.2M

NSE+BSE Volume

High volume today

NSE 10 Oct, 2025 3:31 PM (IST)

HC Order

Delhi HC upholds its order allowing Natco to market a generic version of Roche's Risdiplam in India See details

Natco Pharma Ltd. Earnings/Conference Calls

Natco Pharma Ltd. earnings concalls and investor presentations

Load latest

Is Natco Pharma Ltd. worth buying?

577 Votes:

Buy 83.02%

Sell 7.28%

Hold 9.71%

RESEARCH REPORTS

Hold SEE REPORTS >

Hold SEE REPORTS >